| Primary |
| Epilepsy |
34.1% |
| Complex Partial Seizures |
14.3% |
| Partial Seizures With Secondary Generalisation |
13.4% |
| Simple Partial Seizures |
12.6% |
| Convulsion |
3.9% |
| Grand Mal Convulsion |
3.1% |
| Myoclonic Epilepsy |
2.9% |
| Juvenile Myoclonic Epilepsy |
2.3% |
| Partial Seizures |
1.9% |
| Constipation |
1.7% |
| Lennox-gastaut Syndrome |
1.5% |
| Temporal Lobe Epilepsy |
1.3% |
| Prophylaxis |
1.2% |
| Status Epilepticus |
1.2% |
| Cerebral Infarction |
1.1% |
| Idiopathic Generalised Epilepsy |
0.8% |
| Rasmussen Encephalitis |
0.8% |
| Hypertension |
0.7% |
| Sedative Therapy |
0.7% |
| Convulsion Prophylaxis |
0.5% |
|
| Platelet Count Decreased |
15.3% |
| White Blood Cell Count Decreased |
15.3% |
| Status Epilepticus |
10.2% |
| Somnolence |
8.2% |
| Epilepsy |
7.1% |
| Pneumonia Aspiration |
4.1% |
| Urinary Tract Infection |
4.1% |
| Weight Decreased |
4.1% |
| Brain Neoplasm |
3.1% |
| Ileus Paralytic |
3.1% |
| Lung Neoplasm Malignant |
3.1% |
| Neutropenia |
3.1% |
| Rash |
3.1% |
| Stomatitis |
3.1% |
| Thrombocytopenia |
3.1% |
| Blood Creatine Phosphokinase Increased |
2.0% |
| Cerebral Infarction |
2.0% |
| Colitis Ulcerative |
2.0% |
| Delirium |
2.0% |
| Electrocardiogram Qt Prolonged |
2.0% |
|
| Secondary |
| Epilepsy |
30.5% |
| Complex Partial Seizures |
16.4% |
| Partial Seizures With Secondary Generalisation |
15.9% |
| Simple Partial Seizures |
14.1% |
| Partial Seizures |
5.7% |
| Grand Mal Convulsion |
4.5% |
| Myoclonic Epilepsy |
4.0% |
| Convulsion |
1.8% |
| Juvenile Myoclonic Epilepsy |
1.4% |
| Idiopathic Generalised Epilepsy |
1.1% |
| Constipation |
0.9% |
| Myasthenia Gravis |
0.6% |
| Central Nervous System Lymphoma |
0.5% |
| Gastroenteritis |
0.4% |
| Temporal Lobe Epilepsy |
0.4% |
| Spastic Paralysis |
0.4% |
| Lung Disorder |
0.3% |
| Status Epilepticus |
0.3% |
| Pneumonia |
0.3% |
| Product Used For Unknown Indication |
0.3% |
|
| Status Epilepticus |
17.1% |
| Weight Decreased |
9.9% |
| Retinal Degeneration |
9.4% |
| Epilepsy |
7.2% |
| White Blood Cell Count Decreased |
6.6% |
| Psychiatric Symptom |
6.1% |
| Respiratory Arrest |
6.1% |
| Somnolence |
6.1% |
| Pregnancy |
3.9% |
| Myasthenia Gravis |
3.3% |
| Platelet Count Decreased |
3.3% |
| Convulsion |
2.8% |
| Pancytopenia |
2.8% |
| Umbilical Cord Around Neck |
2.8% |
| Urinary Retention |
2.8% |
| Colitis Ulcerative |
2.2% |
| Lower Limb Fracture |
2.2% |
| Urinary Tract Infection |
2.2% |
| Aortic Dissection |
1.7% |
| Completed Suicide |
1.7% |
|
| Concomitant |
| Epilepsy |
70.6% |
| Gastritis Prophylaxis |
3.2% |
| Gastrointestinal Hypomotility |
3.2% |
| Rash |
3.2% |
| Cardiac Failure Congestive |
2.7% |
| Multiple Sclerosis |
2.1% |
| Pain |
1.6% |
| Temporal Lobe Epilepsy |
1.6% |
| Clostridium Difficile Colitis |
1.1% |
| Dementia |
1.1% |
| Depression |
1.1% |
| Insomnia |
1.1% |
| Partial Seizures |
1.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.1% |
| Subarachnoid Haemorrhage |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Viral Hepatitis Carrier |
1.1% |
| Abdominal Pain |
0.5% |
| Anaemia |
0.5% |
|
| Scab |
20.0% |
| Lymphocyte Count Decreased |
13.3% |
| Drug Eruption |
6.7% |
| Status Epilepticus |
6.7% |
| Acute Respiratory Distress Syndrome |
3.3% |
| Anticonvulsant Drug Level Increased |
3.3% |
| Convulsion |
3.3% |
| Epilepsy |
3.3% |
| Hallucination, Auditory |
3.3% |
| Insomnia |
3.3% |
| Intentional Drug Misuse |
3.3% |
| Neurogenic Bladder |
3.3% |
| Neutrophil Count Decreased |
3.3% |
| Renal Failure Acute |
3.3% |
| Sick Sinus Syndrome |
3.3% |
| Skin Disorder |
3.3% |
| Urinary Tract Infection |
3.3% |
| Viral Rash |
3.3% |
| Visual Impairment |
3.3% |
| Weight Decreased |
3.3% |
|
| Interacting |
| Epilepsy |
66.7% |
| Chronic Myeloid Leukaemia |
33.3% |
|
|
